[18F]GE-226

N/A

Report date: 2025/11/20 16:02:42
NME

Base Information

Drug Name[18F]GE-226
Drug Alias NameGE-226-[18F]Fluorine-18-GE-226[18F]GE-22618F-GE-226
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionSingle-photon emission-computed tomography enhancersReceptor protein-tyrosine kinase erbB-2 antagonistsPositron-emission tomography enhancers
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesAffibody Ab
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of CambridgeGe HealthcareImperial College London
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A